| Jodi Rachel Dotseth, PT | |
|
2321 Stout Rd, Menomonie, WI 54751-7003 | |
| (715) 235-5531 | |
| Not Available |
| Full Name | Jodi Rachel Dotseth |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 2321 Stout Rd, Menomonie, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699794974 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Secondary |
| 225100000X | Physical Therapist | 3980-024 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jodi Rachel Dotseth, PT 200 1st St Sw, Rochester, MN 55905-0001 Ph: (715) 838-5222 | Jodi Rachel Dotseth, PT 2321 Stout Rd, Menomonie, WI 54751-7003 Ph: (715) 235-5531 |
News Archive
Boston University School of Medicine's researchers have found that sociodemographic characteristics are related to a patients' willingness to participate in cancer screenings. They found this was more important than both attitudinal barriers and medical facilitors. This study appears in the March issue of the Journal of the National Medical Association.
Imprimis Pharmaceuticals, Inc., a specialty pharmaceutical company developing non-invasive, topically delivered products, announced that it has signed an agreement with DPT Labs to commence work on supplying Imprimis with quantities of its active topical anti-inflammatory drug, Impracor, for currently planned Phase 3 clinical trials.
CytRx Corporation a biopharmaceutical company specializing in oncology, today announced that it has been awarded a nontaxable grant of approximately $735,000 related to its INNO-206, tamibarotene and bafetinib programs under the Qualifying Therapeutic Discovery Project Program included in the Patient Protection and Affordable Care Act, H.R. 3590, signed into law in March 2010.
Research led by Queen Mary, University of London has found that having asthma is not linked to poorer scores in national school examinations. In contrast, ethnicity and social deprivation were associated with poorer educational outcomes in the study, published in the journal PLOS ONE.
AbbVie released interim results from an ongoing Phase 2 study of its investigational compound veliparib in combination with chemotherapy, which showed a 35 percent improvement (P-value=0.14) in progression-free survival (PFS) and a 30 percent improvement (P-value=0.21) in overall survival (OS) in patients with previously untreated metastatic or advanced non-small cell lung cancer (NSCLC).
› Verified 6 days ago
Hannah Kay Lunde, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2321 Stout Rd, Menomonie, WI 54751 Phone: 715-235-5531 Fax: 715-233-7645 | |
Ms. Marlene Carole Carter Marx, P.T, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 808 Main St E, Menomonie, WI 54751 Phone: 715-231-2771 | |
Amy S Anderson, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2901 Meadowbrook Ln, Menomonie, WI 54751 Phone: 715-309-8045 | |
Bailey Thorgerson, Physical Therapist Medicare: Medicare Enrolled Practice Location: 2407 Stout Rd, Menomonie, WI 54751 Phone: 715-233-7743 | |
Kara Marie Reich, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2108 Broadway St S, Menomonie, WI 54751 Phone: 715-953-2100 | |
John P. Brenegan, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2321 Stout Rd, Menomonie, WI 54751 Phone: 715-235-5531 Fax: 715-233-7645 | |
Christopher J Makuck, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2919 Stout Rd, Menomonie, WI 54751 Phone: 715-717-7455 |